• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience.

作者信息

Meis-Kindblom J M, Bjerkehage B, Böhling T, Domanski H, Halvorsen T B, Larsson O, Lilleng P, Myhre-Jensen O, Stenwig E, Virolainen M, Willén H, Akerman M, Kindblom L G

机构信息

Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

Acta Orthop Scand Suppl. 1999 Jun;285:18-26. doi: 10.1080/17453674.1999.11744818.

DOI:10.1080/17453674.1999.11744818
PMID:10429617
Abstract
摘要

相似文献

1
Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience.
Acta Orthop Scand Suppl. 1999 Jun;285:18-26. doi: 10.1080/17453674.1999.11744818.
2
Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience.软组织和骨肉瘤组织病理学同行评议：诊断分歧的频率及二次病理诊断意见的必要性。东南癌症研究组的经验
J Clin Oncol. 1986 Nov;4(11):1658-61. doi: 10.1200/JCO.1986.4.11.1658.
3
Pitfalls in pathology of soft tissue sarcomas.
Cancer Treat Res. 2004;120:81-97. doi: 10.1007/1-4020-7856-0_5.
4
Pathology of soft tissue sarcomas.
Cancer Treat Res. 1989;44:1-21. doi: 10.1007/978-1-4613-1757-9_1.
5
The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma.斯堪的纳维亚肉瘤研究小组中央登记处：对四肢和躯干壁软组织肉瘤转诊及治疗进行25年监测后的6000例患者情况
Acta Orthop. 2017 Jun;88(3):341-347. doi: 10.1080/17453674.2017.1293441. Epub 2017 Mar 7.
6
The Scandinavian Sarcoma Group Register.斯堪的纳维亚肉瘤研究组登记处。
Acta Orthop Scand Suppl. 1999 Jun;285:41-4. doi: 10.1080/17453674.1999.11744821.
7
Soft tissue sarcomas: classification and natural history.
CA Cancer J Clin. 1981 Sep-Oct;31(5):271-80. doi: 10.3322/canjclin.31.5.271.
8
The Scandinavian Sarcoma Group--background, organization and the SSG Register--the first 25 years.斯堪的纳维亚肉瘤研究组——背景、组织及SSG登记册——最初的25年
Acta Orthop Scand Suppl. 2004 Apr;75(311):1-7. doi: 10.1080/00016470410001708250.
9
[Classification and staging of soft tissue sarcomas].
Acta Biomed Ateneo Parmense. 1982;53(3):153-6.
10
Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.软组织肉瘤的预后因素。综述及斯堪的纳维亚肉瘤研究组的经验
Acta Orthop Scand Suppl. 1999 Jun;285:50-7.

引用本文的文献

1
The Impact of Expert Pathology Review and Molecular Diagnostics on the Management of Sarcoma Patients: A Prospective Study of the Hellenic Group of Sarcomas and Rare Cancers.专家病理审查和分子诊断对肉瘤患者管理的影响：希腊肉瘤和罕见癌症研究组的前瞻性研究
Cancers (Basel). 2024 Jun 24;16(13):2314. doi: 10.3390/cancers16132314.
2
Feasibility and Long-Term Efficacy of PEComa Treatment-20 Years of Experience.PEComa治疗的可行性与长期疗效：20年经验
J Clin Med. 2021 May 19;10(10):2200. doi: 10.3390/jcm10102200.
3
Evaluation of immune-biomarker expression in high-grade soft-tissue sarcoma: HLA-DQA1 expression as a prognostic marker.
高级别软组织肉瘤中免疫生物标志物表达的评估：HLA - DQA1表达作为一种预后标志物。
Exp Ther Med. 2020 Nov;20(5):107. doi: 10.3892/etm.2020.9225. Epub 2020 Sep 18.
4
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.肉瘤：在三个欧洲地区的基于人群的研究中，初始诊断与集中专家审查之间的一致性。
Ann Oncol. 2012 Sep;23(9):2442-2449. doi: 10.1093/annonc/mdr610. Epub 2012 Feb 13.
5
Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.一项前瞻性的流行病学研究，对中央病理审查和分子检测，肉瘤的组织类型和分子亚型的发生率。
PLoS One. 2011;6(8):e20294. doi: 10.1371/journal.pone.0020294. Epub 2011 Aug 3.
6
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.对罗讷-阿尔卑斯地区综合且前瞻性肉瘤患者系列中初始诊断与中心病理复查之间一致性的流行病学评估。
BMC Cancer. 2010 Apr 19;10:150. doi: 10.1186/1471-2407-10-150.
7
Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas.恶性纤维组织细胞瘤中DNA错配修复蛋白MSH2和MSH6的免疫组化缺失
Sarcoma. 2004;8(4):123-7. doi: 10.1155/2004/735237.
8
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.使用组织微阵列对211例恶性纤维组织细胞瘤进行表达谱分析，证实了Ki-67的预后价值。
Virchows Arch. 2004 Sep;445(3):224-30. doi: 10.1007/s00428-004-1065-6. Epub 2004 Aug 7.